US-based pharmaceutical major Pfizer and German biotech firm BioNTech have announced to expand the enrollment of their Phase 3 Covid-19 vaccine trial to up to approximately 44,000 participants, up from an initial recruitment goal of 30,000 individuals.
from Times of India https://ift.tt/3bQdwAU
via IFTTT
from Times of India https://ift.tt/3bQdwAU
via IFTTT
Pfizer, BioNTech to expand vaccine Phase 3 trial
![Pfizer, BioNTech to expand vaccine Phase 3 trial]()
Reviewed by Aamir
on
11:44 PM
Rating:
No comments: